Evidence map›Paper›PMID 38753191›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2025

Glutamate imbalance in key structure of the default mode network in adults with attention-deficit/hyperactivity disorder.

Marcos Vinícius Vidor, Eduardo Schneider Vitola, Cibele Edom Bandeira, Alexandre Ribeiro Martins, Maria Eduarda de Araujo Tavares, Renata Basso Cupertino, Alana Castro Panzenhagen, Bruna Santos da Silva, Isabel Ghirardi Falkenberg, Pedro Olavo Barreto and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marcos Vinícius VidorAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Eduardo Schneider VitolaAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Cibele Edom BandeiraAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Alexandre Ribeiro MartinsQualiphy Soluções Em Imaginologia E Radioproteção, Porto Alegre, Brazil.
Maria Eduarda de Araujo TavaresAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Renata Basso CupertinoAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Alana Castro PanzenhagenAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Bruna Santos da SilvaAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Isabel Ghirardi FalkenbergAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Pedro Olavo BarretoAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Stefania Pigatto TecheAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Felipe Almeida PiconAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Luis Augusto RohdeDepartment of Psychiatry and Behavioral Sciences, PPG Psiquiatria, Federal University of Rio Grande Do Sul (UFRGS), R. Ramiro Barcelos, 2400, 2º Andar, Porto Alegre, RS, Brazil.
Diego L RovarisAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Claiton Henrique Dotto BauAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Eugenio Horacio GrevetAdulthood ADHD Outpatient Program (ProDAH), Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. eugenio.grevet@ufrgs.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The default mode network (DMN) is atypically active in patients with ADHD, likely contributing to the inattention patterns observed in patients with the disorder. Nonetheless, magnetic resonance spectroscopy (MRS) studies have rarely targeted the posterior cingulate cortex, a key DMN region, and little is known about the biochemical setting within this network in patients with ADHD. We aimed to assess the differences in metabolite profiles of the posterior cingulate cortex-a key region of the DMN-between patients with ADHD and controls. Five brain metabolites-glutamate, inositol, N-acetyl aspartate, choline, and creatine-were measured through MRS in the posterior cingulate cortex of patients and controls in a 3.0 T scanner. Between-group comparison of neurometabolite concentrations in PCC was performed using multivariate analysis of covariance. A total of 88 patients and 44 controls were included in the analysis. Patients with ADHD showed lower levels of glutamate in the posterior cingulate cortex compared to controls (p = 0.003). Lower concentrations of glutamate in the posterior cingulate cortex suggest that a glutamatergic imbalance within the posterior cingulate cortex might play a role in the pathogenesis of ADHD. Further understanding of the causes and consequences of such glutamate decrease might help explain how some glutamate-related drug effects impact on ADHD symptomatology.

Indexed as

Attention Deficit Disorder with HyperactivityDefault Mode NetworkGlutamic AcidGyrus CinguliAdultAspartic AcidFemaleHumansInositolMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMaleYoung AdultAspartic AcidGlutamic AcidInositolN-acetylaspartateADHDAttention deficitGlutamateMRSPosterior cingulateSpectroscopy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.